SMMT

Summit Therapeutics
D

SMMT

21.340
USD
-1.31
(-5.76%)
مغلق
حجم التداول
125,864
الربح لكل سهم
-0
العائد الربحي
-
P/E
-21
حجم السوق
15,852,347,980
أصول ذات صلة الأخبار المقالات

العنوان: Summit Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate isridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.